{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:52:10Z","timestamp":1770450730261,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Emerging viral threats such as coronavirus, influenza, Lassa fever, Mpox, and Nipah virus continue to pose significant global health challenges. The development and deployment of effective vaccines are essential for outbreak control and pandemic preparedness. This protocol describes a systematic review that will synthesize evidence on vaccine candidates targeting high-priority viral threats and major vaccine platforms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We will include randomised controlled trials (RCTs) assessing vaccine candidates for specified viruses (coronavirus, Lassa fever, Nipah virus, and Mpox) and platforms (protein-based, viral vector, and RNA) in the human populations. To encompass the full vaccine development landscape, exploratory and preclinical studies may also\u00a0be included (any type of original research). Data sources will include MEDLINE Ovid, Embase Ovid (including ClinicalTrials.gov), and Cochrane Library (including CENTRAL), and grey literature (including conference proceedings, dissertations, trial registries, and company websites). Risk of bias will be assessed using Cochrane revised tool for assessing risk of bias in randomised trials (RoB-2) and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE), and certainty of evidence will be evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE). The primary outcomes are safety, immunogenicity, and vaccine efficacy or effectiveness, prioritised for their critical role in outbreak management and in guiding regulatory approval, public health policy, and clinical decision-making. Meta-analyses will be conducted where appropriate, using both fixed- and random-effects models. Subgroup analyses will be performed to explore heterogeneity based on virus type, vaccine platform, and outcome measures, where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This review will provide a comprehensive synthesis of vaccine development efforts across multiple platforms and pathogens with epidemic or pandemic potential. It will inform future research, policy, and investment decisions in global health preparedness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO 2025 CRD420251082338 on 6 October 2025.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-025-03051-3","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T11:05:04Z","timestamp":1768043104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats"],"prefix":"10.1186","volume":"15","author":[{"given":"Amit","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Sofie Karlsen","family":"Sletten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung Thanh","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig","family":"Tollefsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Jane","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi Delan","family":"Pathirana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"UiB-CEPI Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Beglerovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f8rn","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Albert","family":"Brokstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin Hoffmann","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Hanevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuva Sm\u00e5land","family":"Hagland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorkild","family":"Tyllesk\u00e4r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"101","key":"3051_CR1","doi-asserted-by":"publisher","first-page":"20140950","DOI":"10.1098\/rsif.2014.0950","volume":"11","author":"KF Smith","year":"2014","unstructured":"Smith KF, Goldberg M, Rosenthal S, Carlson L, Chen J, Chen C, et al. Global rise in human infectious disease outbreaks. J R Soc Interface. 2014;11(101):20140950.","journal-title":"J R Soc Interface"},{"issue":"3","key":"3051_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s13280-021-01599-7","volume":"51","author":"C Mishra","year":"2022","unstructured":"Mishra C, Samelius G, Khanyari M, Srinivas PN, Low M, Esson C, et al. Increasing risks for emerging infectious diseases within a rapidly changing High Asia. Ambio. 2022;51(3):494\u2013507.","journal-title":"Ambio"},{"issue":"4","key":"3051_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","volume":"20","author":"RE Baker","year":"2022","unstructured":"Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, et al. Infectious disease in an era of global change. Nat Rev Microbiol. 2022;20(4):193\u2013205.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"3051_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3051_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","volume":"31","author":"RM Lu","year":"2024","unstructured":"Lu RM, Hsu HE, Perez S, Kumari M, Chen GH, Hong MH, et al. Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J Biomed Sci. 2024;31(1):89.","journal-title":"J Biomed Sci"},{"key":"3051_CR6","first-page":"100262","volume":"13","author":"L Hansen","year":"2023","unstructured":"Hansen L, Brokstad KA, Bansal A, Zhou F, Bredholt G, Onyango TB, et al. Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. Vaccine X. 2023;13:100262.","journal-title":"Vaccine: X"},{"key":"3051_CR7","doi-asserted-by":"publisher","first-page":"102370","DOI":"10.1016\/j.coi.2023.102370","volume":"84","author":"M Jeyanathan","year":"2023","unstructured":"Jeyanathan M, Afkhami S, Kang A, Xing Z. Viral-vectored respiratory mucosal vaccine strategies. Curr Opin Immunol. 2023;84:102370.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"3051_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","volume":"7","author":"T Travieso","year":"2022","unstructured":"Travieso T, Li J, Mahesh S, Mello J, Blasi M. The use of viral vectors in vaccine development. NPJ Vaccines. 2022;7(1):75.","journal-title":"NPJ Vaccines"},{"key":"3051_CR9","doi-asserted-by":"crossref","unstructured":"Bansal A. From rejection to the Nobel Prize: Karik\u00f3 and Weissman\u2019s pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology. Front Immunol. 2023;14:1306025.","DOI":"10.3389\/fimmu.2023.1306025"},{"key":"3051_CR10","doi-asserted-by":"publisher","first-page":"1164326","DOI":"10.3389\/fpubh.2023.1164326","volume":"11","author":"A Bansal","year":"2023","unstructured":"Bansal A, Trieu M-C, Mohn KG, Madsen A, Olofsson JS, Sandnes HH, et al. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. Front Public Health. 2023;11:1164326.","journal-title":"Front Public Health"},{"issue":"1","key":"3051_CR11","doi-asserted-by":"publisher","first-page":"2520861","DOI":"10.1080\/20523211.2025.2520861","volume":"18","author":"S Suphap","year":"2025","unstructured":"Suphap S, Luksameesate P, Nerapusee O, Anantachoti P. A scoping review of authorisation pathway for COVID-19 vaccines among selected countries. J Pharm Policy Pract. 2025;18(1):2520861.","journal-title":"J Pharm Policy Pract"},{"key":"3051_CR12","doi-asserted-by":"crossref","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group PP: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","DOI":"10.1186\/2046-4053-4-1"},{"issue":"1","key":"3051_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/epirev\/mxz012","volume":"41","author":"D Gouglas","year":"2019","unstructured":"Gouglas D, Christodoulou M, Plotkin SA, Hatchett R. CEPI: driving progress toward epidemic preparedness and response. Epidemiol Rev. 2019;41(1):28\u201333.","journal-title":"Epidemiol Rev"},{"key":"3051_CR14","doi-asserted-by":"crossref","unstructured":"Kim J, Sabet-Azad R, Patel D, Malin G, Askary SH, Sarnefalt A: Fast-tracking vaccine manufacturing: CEPI's rapid response framework for the 100 days mission. Vaccines (Basel). 2025;13(8):849.","DOI":"10.3390\/vaccines13080849"},{"issue":"1","key":"3051_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12915-023-01686-z","volume":"21","author":"K Hair","year":"2023","unstructured":"Hair K, Bahor Z, Macleod M, Liao J, Sena ES. The automated systematic search deduplicator (ASySD): a rapid, open-source, interoperable tool to remove duplicate citations in biomedical systematic reviews. BMC Biol. 2023;21(1):189.","journal-title":"BMC Biol"},{"issue":"1","key":"3051_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13643-024-02682-2","volume":"13","author":"L Ge","year":"2024","unstructured":"Ge L, Agrawal R, Singer M, Kannapiran P, De Castro Molina JA, Teow KL, et al. Leveraging artificial intelligence to enhance systematic reviews in health research: advanced tools and challenges. Syst Rev. 2024;13(1):269.","journal-title":"Syst Rev"},{"key":"3051_CR17","doi-asserted-by":"crossref","unstructured":"Sabet-Azad R, Hoath C, Bezay N, Sarnefalt A. The platform readiness dashboard: a tool for evaluating vaccine platform suitability for a rapid response to epidemic and pandemic threats. Vaccines (Basel). 2025;13(8):793.","DOI":"10.3390\/vaccines13080793"},{"issue":"4","key":"3051_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"key":"3051_CR19","unstructured":"Schwarzer G, Carpenter J, R\u00fccker G. metasens: statistical methods for sensitivity analysis in meta-analysis. In.: The comprehensive R archive network; 2023."},{"key":"3051_CR20","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u2013926.","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"3051_CR21","unstructured":"Bansal A, Sletten ISK, Le TT, Shannon J, Cox RJ, Pathirana RD. Systematic review protocol: establishment and analysis of landscapes for candidate platforms and vaccines against current and emerging viral threats. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251082338."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-03051-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-03051-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-03051-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:16:02Z","timestamp":1770390962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-025-03051-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3051"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-03051-3","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Ethics approval is not required as this review involves secondary data. The findings of this systematic review can be published in peer-reviewed open access journals. The results can be disseminated through presentations at scientific conferences and reports to relevant stakeholders in consultation and collaboration with the CEPI team members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}